Mode
Text Size
Log in / Sign up

Cerebellum functions as a modulatory component in migraine networks rather than a primary attack generatorCGRP Treatment Shows Changes in Migraine Related Brain Networks

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that the cerebellum is a modulatory component of migraine networks, not a validated treatment target.

This narrative review explores the role of the cerebellum in migraine, vestibular migraine, medication-overuse headache, and familial hemiplegic migraine. The review synthesizes findings from repeated-measures imaging, structural studies, and trigeminal stimulation to map the cerebellum's involvement in migraine pathophysiology.

Key findings indicate that repeated-measures imaging suggests changes across the migraine cycle, though these results are based on small cohorts. Structural findings vary significantly based on the analytic method used, and population-based testing does not show a general cerebellar deficit in common migraine. Trigeminal stimulation is noted to recruit lobules VI/VIIIa and Crus I, while vestibular migraine involves posterior cerebellar and wider vestibular-sensory networks. Treatment imaging shows cerebellar changes but does not localize the specific site of CGRP-directed action.

The authors note significant limitations, including small cohort sizes in imaging studies and variability in structural findings. The clinical takeaway is that the cerebellum acts as a modulatory component of distributed migraine networks. It is not currently considered a demonstrated attack generator or a validated target for treatment. Clinical application of these findings is currently limited by the lack of localized action sites for CGRP-directed therapies.

How this fits prior evidence

This narrative review addresses a gap in understanding the specific role of the cerebellum in migraine pathophysiology. It complements prior coverage of non-pharmacological and pharmacological interventions, such as the potential of taVNS for migraine and the use of propranolol for managing migraine. While previous evidence highlighted the potential of these treatments, this review clarifies that the cerebellum is a modulatory component rather than a primary attack generator or validated treatment target.

Researchers reviewed imaging data to see how the cerebellum, a part of the brain that helps coordinate movement and balance, relates to migraines. They looked at patients with various types of migraines, including vestibular migraine and medication-overuse headache. The review looked at how these patients responded to CGRP-directed treatments.

Imaging showed that the cerebellum is part of a large network involved in migraine. While some studies showed changes in the cerebellum during the migraine cycle, these studies used very small groups of people. Other tests showed that common migraines do not always cause a general deficit in this part of the brain.

It is important to note that while the cerebellum is involved in migraine networks, it is not currently considered the primary source of a migraine attack. It is also not yet a confirmed target for specific treatments. Because the data comes from small groups and different testing methods, these findings are not yet enough to change standard medical practices.

What this means for you:
CGRP treatments show changes in the cerebellum, but it is not yet a confirmed target for migraine treatment.

Common questions

What is the role of the cerebellum in migraines?

The cerebellum is considered a modulatory component of the brain networks involved in migraines. While it is part of these networks, it is not currently proven to be the site that generates a migraine attack or a confirmed target for specific medical treatments.

What did the imaging show about CGRP treatment?

Imaging showed changes in the cerebellum during treatment. However, these images did not pinpoint the exact location where CGRP acts. Because the study groups were small, these results are currently used to understand brain networks rather than to change specific treatment plans.

Is the cerebellum affected in all types of migraines?

Research shows that vestibular migraines involve the posterior cerebellum and wider sensory networks. However, population-based testing did not show a general cerebellum deficit in cases of common migraine.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedOct 2026
View Original Abstract ↓
Migraine is usually framed through trigeminovascular pathways and interactions among the brainstem, hypothalamus, and cortex. The cerebellum has received less attention, although human studies place it within circuits that process trigeminal nociception and vestibular signals. This narrative review examines anatomical and experimental work together with imaging, genetic, and clinical studies, giving greatest weight to direct human migraine evidence. Repeated-measures imaging suggests that cerebellar connectivity changes across the migraine cycle, but the cohorts are small. Structural findings vary with analytic method, and population based testing does not show a general cerebellar deficit in common migraine. Evidence is more coherent in defined contexts: trigeminal stimulation recruits lobules VI/VIIIa and Crus I, vestibular migraine involves posterior cerebellar and wider vestibular-sensory networks, and treatment imaging shows cerebellar changes without localizing the site of CGRP-directed action. Findings in medication-overuse headache and familial hemiplegic migraine provide additional state-related and mechanistic clues. Taken together, the cerebellum is best viewed as a modulatory component of distributed migraine networks, with possible roles in sensory gain and vestibular integration. It is neither a demonstrated attack generator nor a validated treatment target. The next step is to test whether within-person cerebellar measures reproduce across attacks and whether intervention changes a prespecified circuit-level endpoint.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.